Mylan Launches Generic Version of Tecfidera for MS
This is the first FDA-approved therapeutically equivalent, substitutable generic of Tecfidera.
This is the first FDA-approved therapeutically equivalent, substitutable generic of Tecfidera.
Vitamin D supplements may significantly improve neuropathic symptoms, including pain and quality of life.
The microbiota-gut-brain axis represents a bidirectional communication pathway through which the gut microbiota may influence the CNS.
Healthcare professionals see the benefits of prescribing cannabis therapies but report significant knowledge gaps in both recreational and medical cannabis.
To dig deeper into the study and its importance for a growing field, we spoke with Laura H. Goldstein, PhD, of the Department of Psychology, King’s College London, United Kingdom.
Precision medicine offers a promising therapeutic strategy for patients with Parkinson disease, allowing for tailored treatments which reflect the unique pathophysiology in each patient.
The ENSG-WFN published a report that details current understanding of the neurologic impacts of COVID-19.
The management of painful diabetic peripheral neuropathy requires the use of effective agents that also may aid in improving sleep and mood.
Exposure to air pollution may have adverse effects on cognitive aging and brain health in older adults.
Compared to the general population, patients with newly diagnosed MS/CIS are more likely to have impaired cognitive function.